Wuhan Keqian Biology Co.,Ltd (SHA:688526)
China · Delayed Price · Currency is CNY 12.90
-0.08 (-0.62%)
Aug 4, 2026, 3:00 PM CST
SHA:688526 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 932.09 | 949.74 | 941.92 | 1,064 | 1,001 | 1,103 |
Revenue Growth | -5.10% | 0.83% | -11.48% | 6.27% | -9.22% | 30.81% |
Gross Profit Gross Profit Growth | 603.13 | 619.03 | 581.48 | 742.65 | 722.22 | 872.6 |
Operating Income Operating Income Growth | 343.63 | 371.23 | 315.01 | 357.29 | 383.21 | 575.71 |
Net Income Net Income Growth | 389.72 | 418.72 | 382.35 | 395.93 | 409.52 | 570.74 |
Earnings Per Share EPS Growth | 0.84 | 0.90 | 0.82 | 0.85 | 0.88 | 1.23 |
EPS Growth | -3.66% | 9.76% | -3.53% | -3.41% | -28.46% | 6.03% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Veterinary Biological Products Industry Veterinary Biological Products Industry Growth | 890.43 |
Other Other Growth | 45.22 |
Total Total Growth | 935.65 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 2,596 | 2,383 | 1,932 | 1,778 | 1,941 | 1,316 |
Total Debt Total Debt Growth | 6.34 | 6.68 | 6.9 | 293.51 | 279.48 | 78.09 |
Net Cash (Debt) Net Cash Growth | 2,590 | 2,377 | 1,925 | 1,484 | 1,661 | 1,238 |
Net Cash Growth | 94.45% | 23.45% | 29.70% | -10.65% | 34.25% | -41.73% |
Net Cash Per Share Net Cash Per Share Growth | 5.58 | 5.11 | 4.13 | 3.19 | 3.57 | 2.67 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 378.98 | 468.54 | 392.68 | 538.03 | 423.71 | 531.27 |
Capital Expenditures CapEx Growth | -119.24 | -123.88 | -106.94 | -104.5 | -102.85 | -374.45 |
Free Cash Flow Free Cash Flow Growth | 259.74 | 344.66 | 285.74 | 433.53 | 320.86 | 156.82 |
Free Cash Flow Growth | -8.91% | 20.62% | -34.09% | 35.12% | 104.60% | -45.65% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 64.71% | 65.18% | 61.73% | 69.79% | 72.13% | 79.11% |
Operating Margin | 36.87% | 39.09% | 33.44% | 33.58% | 38.27% | 52.19% |
Pretax Margin | 47.87% | 50.70% | 46.51% | 43.00% | 46.60% | 59.84% |
Profit Margin | 41.81% | 44.09% | 40.59% | 37.21% | 40.90% | 51.74% |
FCF Margin | 27.87% | 36.29% | 30.34% | 40.74% | 32.05% | 14.22% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.640 | 0.640 | 0.430 | 0.430 | 0.190 | 0.190 |
Dividend Per Share Growth | 48.84% | 48.84% | 0% | 126.32% | 0% | -34.48% |
Dividend Yield | 4.93% | 4.39% | 3.24% | 2.32% | 0.94% | 0.77% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 15.36 | 16.91 | 17.36 | 24.00 | 25.50 | 22.44 |
Forward PE | 12.77 | 14.51 | 13.51 | 14.86 | 16.95 | 17.49 |
P/FCF Ratio | 23.04 | 20.54 | 23.22 | 21.91 | 32.55 | 81.65 |
PS Ratio | 6.42 | 7.45 | 7.05 | 8.93 | 10.43 | 11.61 |